Reply: Regarding terlipressin-related patient outcomes in hepatorenal syndrome-acute kidney injury.

Autor: Premkumar M; Department of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, India., Kulkarni A; Department of Hepatology, Asian Institute of Gastroenterology, Hyderabad, India., Izzy M; Division of Gastroenterology, Hepatology, and Nutrition, Vanderbilt University, Nashville, Tennessee, USA.

Publikováno v: Hepatology (Baltimore, Md.) [Hepatology] 2024 Nov 01; Vol. 80 (5), pp. E79-E80. Date of Electronic Publication: 2024 Jun 26.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Terlipressin use in hepatorenal syndrome-acute kidney injury in cirrhosis. Author's reply.

Autor: Nadim MK; Division of Nephrology and Hypertension, Keck School of Medicine, University of Southern California, Los Angeles, USA., Forni LG; Critical Care Unit, Royal Surrey Hospital Foundation Trust, Guildford, UK.; School of Medicine, Kate Granger Building, University of Surrey, Guildford, UK., Ostermann M; Department of Intensive Care, King's College London, Guy's and St Thomas' Hospital, London, UK. Marlies.Ostermann@gstt.nhs.uk.

Publikováno v: Intensive care medicine [Intensive Care Med] 2024 Nov 21. Date of Electronic Publication: 2024 Nov 21.

Comparative efficacy of terlipressin and norepinephrine for treatment of hepatorenal syndrome-acute kidney injury: A systematic review and meta-analysis.

Autor: Olson, Jody C.¹ (AUTHOR) olson.jody3@mayo.edu, Subramanian, Ram M.² (AUTHOR)

Publikováno v: PLoS ONE. 1/29/2024, Vol. 19 Issue 1, p1-14. 14p.

Hepatorenal Syndrome–Acute Kidney Injury in Liver Transplantation

Autor: Lizaola-Mayo, Blanca, Vargas, Hugo E.

Publikováno v: In Clinical Gastroenterology and Hepatology September 2023 21(10) Supplement:S20-S26